Amelioration of dystrophic epidermolysis bullosa pruriginosa symptoms with dupilumab: A case report.

Authors	Yangbin Wang, Mingming Zhou, Li Zhang, Song Zheng, Yuxiao Hong, Xing-Hua Gao
Journal	Dermatologic therapy (Dermatol Ther) Vol. 34 Issue 6 Pg. e15130 (11 2021) ISSN: 1529-8019 [Electronic] United States
PMID	34528352 (Publication Type: Case Reports, Letter)
Chemical References	Antibodies, Monoclonal, Humanized Collagen Type VII dupilumab
Topics	Antibodies, Monoclonal, Humanized (therapeutic use) Collagen Type VII Epidermolysis Bullosa Epidermolysis Bullosa Dystrophica (diagnosis, drug therapy) Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!